Vaccitech Domain Overviewđź”’ SSL Verified
Live Data Status: |E-commerce & Retail
Welcome to the detailed analysis for vaccitech.co.uk. This domain is officially recognized as Barinthus Biotherapeutics. According to their official web presence, their primary focus is: "Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.".
Table of Contents
- ↓ Guiding the immune system to cure disease
- ↓ To advance the next generation of immunotherapies that lead T cells to gain control over disease and improve patients’ lives.
- ↓ Barinthus Biotherapeutics Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
- ↓ Barinthus Biotherapeutics Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
- ↓ Barinthus Biotherapeutics Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
- ↓ Helping patients and their families is the guiding principle at the heart of Barinthus Biotherapeutics.
- ↓ Top Alternatives to vaccitech.co.uk
- Tech Stack
- Custom Built / Unknown
- Link Profile
- Internal Pages: 13Outbound Links: 43
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$13,951
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- vaccitech.comTaken
- vaccitech.netTaken
- vaccitech.orgTaken
- vaccitech.ioTaken
- vaccitech.coTaken
- vaccitech.aiTaken
Official Contact & Profiles
Socials:twitter.comlinkedin.com
Content Snippets from vaccitech.co.uk
"VTP-200 was generally well-tolerated and was administered with no product-related grade 3 unsolicited adverse events and no product-related serious adverse events (SAEs) in women with low grade human papillomavirus-related cervical lesions…"
"Completed Phase 1b/2a trial of VTP-300 met its primary and secondary endpoints VTP-300 is the first antigen-specific immunotherapy shown to induce sustained reductions in Hepatitis B surface antigen (HBsAg) Results will be presented at the upcoming European Association for the Study of the Liver (EASL)…"
"20400 Century Blvd.Suite 210Germantown, MD 20874United States of America"
"Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer."
Key Topics & Focus Areas for vaccitech.co.uk:
Guiding the immune system to cure disease
To advance the next generation of immunotherapies that lead T cells to gain control over disease and improve patients’ lives.
Barinthus Biotherapeutics Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
Barinthus Biotherapeutics Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
Barinthus Biotherapeutics Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
Helping patients and their families is the guiding principle at the heart of Barinthus Biotherapeutics.
By comparing vaccitech.co.uk to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to vaccitech.co.uk.
Frequently Asked Questions
Is vaccitech.co.uk a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of vaccitech.co.uk?
As of July 29, 2026, vaccitech.co.uk holds an estimated domain authority score of 64/100 based on our VisitRank tracking algorithms.
What are the top alternatives to vaccitech.co.uk?
You can find the best alternatives and similar sites to vaccitech.co.uk in our explore section, which includes competitors in the E-commerce & Retail sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for vaccitech.co.uk:
vcacitech.covacitech.covaaccitech.coveccitech.covaccotech.covaccitach.covqccitech.covsccitech.co